Treatment of oncogene-driven non-small cell lung cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pulmonary and Respiratory Medicine
Reference70 articles.
1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009
2. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003;Yang;Chest,2005
3. Chemotherapy can prolong survival in patients with advanced nonsmall-cell lung cancer--report of a Canadian multicenter randomized trial;Rapp;J Clin Oncol,1988
4. First line chemotherapy in advanced or metastatic NSCLC;Rinaldi;Ann Oncol,2006
5. Chemotherapy and supportive care versus supportive care alone for advanced nonsmall cell lung cancer.;Cochrane Database Syst Rev,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role and Therapeutic Potential of Non-coding RNAs in Resistance to EGFR-TKIs targeted therapy for Non-small Cell Lung Cancer;Current Medicinal Chemistry;2024-02-16
2. Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer;Prague Medical Report;2023
3. The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC;Scientific Reports;2021-12
4. Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib;Clinical Lung Cancer;2021-11
5. Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling;Cells;2020-12-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3